Company news
Insmed Incorporated news
Latest news releases, newest first. Pick a year for every news release, call and deck from that year.
Insmed and Google Cloud Collaborate to Transform the Lives of Patients by Harnessing the Power of AI
October 23, 2023
Insmed to Host Third-Quarter 2023 Financial Results Conference Call on Thursday, October 26, 2023
October 11, 2023
Insmed To Present at Chardan's 7th Annual Genetic Medicines Conference
September 25, 2023
Insmed To Present at the Morgan Stanley 21st Annual Global Healthcare Conference
September 5, 2023
Insmed announces positive topline results from Phase 3 ARISE study of ARIKAYCE® (amikacin liposome inhalation suspension) in patients with NTM lung disease caused by MAC
September 4, 2023
Insmed Reports Second-Quarter 2023 Financial Results and Provides Business Update
August 2, 2023
Insmed to Host Second-Quarter 2023 Financial Results Conference Call on Thursday, August 3, 2023
July 19, 2023
Insmed To Present at the Goldman Sachs 44th Annual Global Healthcare Conference
June 6, 2023
Insmed Presents Range of New Study Findings at American Thoracic Society 2023 International Conference
May 21, 2023
Insmed Unveils New Research Platforms and Capabilities at Investor and Analyst Event, "The Future of Rare at Insmed: Functional Genes, AI-Enhanced Proteins, Glowing Algae, and More"
May 7, 2023
Insmed Reports First Quarter 2023 Financial Results and Provides Business Update
May 3, 2023
Insmed to Host Investor and Analyst Event on May 8, 2023
April 23, 2023
Insmed to Host First Quarter 2023 Financial Results Conference Call on Thursday, May 4, 2023
April 19, 2023
Insmed Completes Enrollment of Adult Patients in Phase 3 ASPEN Study of Brensocatib in Bronchiectasis
March 30, 2023
Insmed to Present New Clinical, Pre-Clinical, and Real-World Data in Serious and Rare Lung Diseases at the American Thoracic Society 2023 International Conference
March 23, 2023
Insmed To Present at Two March Conferences
February 28, 2023
Insmed Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Business Update
February 22, 2023
Insmed to Host Fourth Quarter and Full Year 2022 Financial Results Conference Call on Thursday, February 23, 2023
February 8, 2023
Insmed To Present at the SVB Securities Global Biopharma Conference
February 6, 2023
Insmed Provides Business Updates and Near-Term Strategic Outlook at 41st Annual J.P. Morgan Healthcare Conference
January 5, 2023
Insmed To Present at the 41st Annual J.P. Morgan Healthcare Conference
January 2, 2023
Insmed To Present at the Nasdaq 47th Investor Conference
November 29, 2022
Insmed To Present at Three November Conferences
October 31, 2022
Insmed Reports Third Quarter 2022 Financial Results and Provides Business Update
October 26, 2022
Insmed Ranks No. 1 on Science's 2022 Top Biopharma Employers List
October 26, 2022
Insmed Announces Strategic Financings Totaling $775 Million
October 18, 2022
Insmed to Host Third Quarter 2022 Financial Results Conference Call on Thursday, October 27, 2022
October 12, 2022
Insmed Holds Inaugural Global Day of Good - A Company-Wide Day of Service
October 5, 2022
Insmed To Present at Two September Conferences
September 5, 2022
Insmed Reports Second Quarter 2022 Financial Results and Provides Business Update
August 3, 2022
Insmed to Host Second Quarter 2022 Financial Results Conference Call on Thursday, August 4, 2022
July 20, 2022
Insmed Names Drayton Wise Chief Commercial Officer
May 22, 2022
Insmed To Present at the H.C. Wainwright Annual Global Life Sciences Conference
May 16, 2022
Insmed Presents New Data Across Three Pillars at American Thoracic Society 2022 International Conference
May 16, 2022
Insmed Reports First Quarter 2022 Financial Results and Provides Business Update
May 4, 2022
Insmed to Host First Quarter 2022 Financial Results Conference Call on Thursday, May 5, 2022
April 20, 2022
Insmed to Showcase New Data Across Three Pillars at the American Thoracic Society 2022 International Conference
March 27, 2022
Insmed To Present at the Cowen 42nd Annual Health Care Conference
March 2, 2022
Insmed Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Business and Pipeline Update
February 16, 2022
Insmed To Present at the SVB Leerink Virtual 11th Annual Global Healthcare Conference
February 9, 2022
Insmed to Host Fourth Quarter and Full Year 2021 Financial Results Conference Call and Provide a Business and Pipeline Update on Thursday, February 17, 2022
January 26, 2022
Insmed To Present at the 40th Annual J.P. Morgan Healthcare Conference
January 3, 2022
Insmed To Participate in Three November Conferences
November 2, 2021
Insmed Reports Third Quarter 2021 Financial Results and Provides Business Update
October 27, 2021
Insmed Ranks No. 1 on Science's 2021 Top Biopharma Employers List
October 27, 2021
Insmed to Host Third Quarter 2021 Financial Results Conference Call on Thursday, October 28, 2021
October 13, 2021
Insmed To Participate in Five September Conferences
August 31, 2021
Insmed Reports Second Quarter 2021 Financial Results and Provides Business Update
August 4, 2021
Insmed to Host Second Quarter 2021 Financial Results Conference Call on Thursday, August 5, 2021
July 26, 2021
Insmed To Present at Two June Conferences
May 24, 2021
Calls
The 5 newest of 23 calls. Every call is listed under its year.
- Insmed (NASDAQ:INSM) Q3 2026 Earnings Call
Oct 29, 2026
Transcript - Insmed (NASDAQ:INSM) Q2 2026 Earnings Call
Aug 6, 2026
Transcript - Insmed (NASDAQ:INSM) Q1 2026 Earnings Call
May 7, 2026
Transcript - Insmed (NASDAQ:INSM) Q4 2025 Earnings Call
Feb 19, 2026
Transcript - Insmed (NASDAQ:INSM) Q3 2025 Earnings Call
Oct 30, 2025
Transcript
Decks
The 5 newest of 49 decks. Every deck is listed under its year.
- Q3 2026 Earnings Presentation
Earnings · 27 slides · Oct 29, 2026
- Investor Presentation (October 2026)
Investor deck · 99 slides · October 2026
- Q2 2026 Earnings Presentation
Earnings · 27 slides · Aug 6, 2026
- Investor Presentation (August 2026)
Investor deck · 97 slides · August 2026
- Technical Presentation (July 2026)
Technical · 27 slides · Jul 16, 2026